Strobach, D.; Haimerl, L.; Mannell, H.; Stief, C.G.; Karl, A.; Grimm, T.; Buchner, A.
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study. J. Clin. Med. 2023, 12, 6749.
https://doi.org/10.3390/jcm12216749
AMA Style
Strobach D, Haimerl L, Mannell H, Stief CG, Karl A, Grimm T, Buchner A.
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study. Journal of Clinical Medicine. 2023; 12(21):6749.
https://doi.org/10.3390/jcm12216749
Chicago/Turabian Style
Strobach, Dorothea, Lisa Haimerl, Hanna Mannell, Christian G. Stief, Alexander Karl, Tobias Grimm, and Alexander Buchner.
2023. "The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study" Journal of Clinical Medicine 12, no. 21: 6749.
https://doi.org/10.3390/jcm12216749
APA Style
Strobach, D., Haimerl, L., Mannell, H., Stief, C. G., Karl, A., Grimm, T., & Buchner, A.
(2023). The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study. Journal of Clinical Medicine, 12(21), 6749.
https://doi.org/10.3390/jcm12216749